STEVEN GILMAN, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Vericel Corp

Filing Date Source Excerpt
2016-03-18 Dr. Gilman received his Ph.D. and M.S. degrees in microbiology from Pennsylvania State University, his post-doctoral training at Scripps Clinic and Research Foundation, and received a B.A. in microbiology from Miami University of Ohio.
2017-03-20 Dr. Gilman received his Ph.D. and M.S. degrees in microbiology from Pennsylvania State University, his post-doctoral training at Scripps Clinic and Research Foundation, and received a B.A. in microbiology from Miami University of Ohio.
2019-03-20 Dr. Gilman received his B.A. in microbiology from Miami University of Ohio, Ph.D. and M.S. degrees in microbiology from Pennsylvania State University, and his post-doctoral training at Scripps Clinic and Research Foundation.
2024-03-21 Dr. Gilman served as Executive Vice President, Research & Development and Chief Scientific Officer at Cubist Pharmaceuticals and has a Ph.D. in microbiology.

Data sourced from SEC filings. Last updated: 2025-10-11